Louis G. Lange, Director at Audentes Therapeutics, Inc. (BOLD), sold 17,000 shares at $30.88 ($525K) on 2017-12-22, disclosed to the SEC on 2017-12-26.
Open-market sale of $525k BOLD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.86 | 1,000 | $31K | 5.9% |
| 2 | $30.88 | 15,000 | $463K | 88.2% |
| 3 | $30.90 | 1,000 | $31K | 5.9% |
| Total | $30.88 avg | 17,000 | $525K | 100% |
| Filing → |
| NAMS | BUY | 2024-02-21 | $95K | — | Filing → |
| BOLD | SELL | 2019-12-27 | $656K | — | Filing → |
| BOLD | SELL | 2019-09-25 | $667K | — | Filing → |